Cancer — Net premium income
Aflac Cancer — Net premium income remained flat by 0.0% to $1.76B in Q4 2021 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful product penetration, higher policy renewals, or effective pricing strategies within the cancer insurance market. A decrease may signal heightened competition, product maturity, or a strategic shift in the company's underwriting focus.
Detailed definition
This metric represents the total revenue generated from insurance policies specifically covering cancer-related health r...
Peer comparison
Comparable to specific product-line premium revenue reported by other life and health insurers, often categorized under supplemental health or specialty insurance segments.
afl_segment_cancer_net_premium_incomeHistorical Data
| FY'21 | |
|---|---|
| Value | $7.05B |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Aflac's cancer — net premium income?
- Aflac (AFL) reported cancer — net premium income of $1.76B in Q4 2021.
- What does cancer — net premium income mean?
- The total revenue earned from cancer insurance policies after accounting for reinsurance costs.